Become a Volunteer and Help Build the Global Directory of Oncologists

Volunteer

FDA Final Guidances on Clinical Trial Safety Reporting: What Investigators and Sponsors Need to Know

FDA Final Guidances - OncoDaily

Deep Dive Into the Latest Consensus on Advanced Breast Cancer Management - SPCC

SPCC

Marty Makary Recaps FDA Changes so far Under President Trump’s Leadership

Marty Makary

Sacituzumab Govitecan Plus Pembrolizumab as First-Line Therapy in mNSCLC: EVOKE-02 Study

Sacituzumab Govitecan

Oncology News, Insights, Stories by OncoDaily

100 Most Influential People
OncoDaily 100

The 100 Most Influential People in Oncology in 2025 (Full List)

ASCO Announces Newly Elected Board of Directors and Nominating Committee Members 2027-28
OncoIndustry

ASCO Announces Newly Elected Board of Directors and Nominating Committee Members 2027-28

Evis Sala
OncoDaily Magazine

Evis Sala: Returning Home to Transform Healthcare

The Angelina Jolie Effect: A Lasting Global Impact on Cancer Prevention

FY26 FDA Broad Agency Announcement: Advanced Research and Development of Regulatory Science

New ESTRO-ISRS Clinical Guidelines

All 2026 Current Myeloma Algorithms by Vincent Rajkumar

The FDA Has Granted BeOne's Bispecific Antibody Fast Track Designation in HCC

Deb Schrag Is Elected as the 2027-2028 President of ASCO

IASLC Introduces VIKTOR: Virtual International Knowledgebase for Thoracic Oncology Research

OncoThon 2026
OncoDaily 100
Act 4 Children
Grand Rounds GI
OncoDaily Party: Berlin 2025
awards
awards
awards
awards
awards
awards

Voices
Paolo Tarantino

Paolo Tarantino: 10 Major Milestones in Breast Cancer Care over the Past 5 Years

Amy Moore: Wrapping Up the Last Few Things before Taking Some Time to Spend with Loved Ones

AIEOP Bone Sarcoma Working Group News

SIOP NA and SLAOP Invite Session Ideas for Combined Conference Ahead of SIOP 2026

Robotic Surgery Enters Clinical Practice in Armenia for the First Time

Hadieh Eslampanah: A Meaningful Conversation on the Power of Technology, Community, and Long-Term Impact

John V. Oyler: Exploring How AI Can Transform the Blood Cancer Patient Journey at ASH 2025

FDA Approvals
FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approves RYBREVANT FASPRO as the First Subcutaneous Amivantamab Option for EGFR-Mutated NSCLC

FDA Approved Rucaparib for BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer

FDA Approves Fam-Trastuzumab Deruxtecan-nxki With Pertuzumab for First-Line Treatment of HER2-Positive Metastatic Breast Cancer

FDA Approves Niraparib Plus Abiraterone for BRCA2-Mutated Metastatic Castration-Sensitive Prostate Cancer

New Hope for NUT Carcinoma: FDA Grants Orphan Drug Status to ZEN-3694

FDA approved Durvalumab plus FLOT for resectable gastric or GEJ adenocarcinoma

FDA Approves Pembrolizumab + Enfortumab Vedotin-ejfv for Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

OncoDaily 100
100 Most Influential People

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024

Top 100 Xfluencers in Pediatric Hematology/Oncology: Key Opinion Leaders to follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

Best of SABCS – West

Association of Northern California Oncologists

14 Feb
SABCS

ANCO's Hematologic Malignancies Update 2026

Association of Northern California Oncologists

02 May
ANCO

26th Multidisciplinary Management of Cancers: A Case-Based Approach

Association of Northern California Oncologists

06 Mar
cancers

ANCO's Clinical Cancer Update 2026

Association of Northern California Oncologists

23 Jan
anco

ANCO’s Medicare Regulations Update 2026

Association of Northern California Oncologists

14 Jan
ANCO

Immune-oncology
10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

Positive Topline Results from Phase 3 RINGSIDE Trial: Varegacestat Significantly Improves Outcomes in Desmoid Tumors

How Do Pharmacists Protect the Safety and Effectiveness of Immunotherapy?

10 Must-Read Posts in Immuno-Oncology This Week

10 Must-Read Posts in Immuno-Oncology This Week

The "Off-the-Shelf" Revolution: How iNKT Cell Therapy agenT-797 is Reprogramming the Fight Against Solid Tumors

10 Posts Not to Miss from ESMO

OncoDaily TV
Global Health Dialogues

Global Health Dialogues with Princess Dina Mired: Prof. Kofi Mensah Nyarko

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Global Health Dialogues with Princess Dina Mired | Episode 3: HE Dr. Ahmed Mohammed Obaid Al Saidi

Mina S. Sedrak

Mina S. Sedrak: Shaping the Future of Cancer and Aging Research, Redefining Survivorship

Yuman Fong

Yuman Fong: Exclusive Interview on Innovation, Mentorship and the Future of Surgical Oncology

Immunotherapy in Nigeria

Opening New Frontiers for Cancer Care in Africa: Bringing Colorectal Cancer Immunotherapy in Nigeria

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

The Asher Series Survivorship and Beyond Presented by OncoDaily LA

Gregory Kalemkerian

60 questions about SCLC with Dr. Gregory Kalemkerian Part 1

Mohamed Osman

ONCOFFEE: Mohamed Osman – Building a Research Career from Egypt to New York

Susan G. Komen

How Is Susan G. Komen Changing the Future of Breast Cancer Care?

Sarah J. Winston

How Sara J. Winston Transformed Her Multiple Sclerosis Diagnosis Into a Story of Art and Healing

Beyond the Cancer Diagnosis

Beyond the Cancer Diagnosis: Interview with Michelle Peate, Hosted by Adrian Pogacian

Empowering Oncologists Yüksel Ürün

Empowering Oncologists: How my professional enthusiasm made me a global leader in Oncology?

Not To Miss
OncoDaily Weekly

Oncology This Week: OncoDaily Weekly Dec 8–14, 2025

25 Posts Not to Miss from SABCS 2025

20 Posts Not to Miss from SABCS 2025, Part 2

25 Posts Not to Miss from ASH 2025

15 Posts Not to Miss from SABCS 2025, Part 1

20 Posts Not to Miss from ASH 2025, Part 2

Oncology This Week: OncoDaily Weekly Dec 1-7

OncoGrants
Cancer Council ACT Research Grants

Cancer Council ACT Research Grants

Supporting People with Cancer Grant Program

Supporting People with Cancer Grant Program

Networking for Cancer Equity Grant Program

Networking for Cancer Equity Grant Program

Brain Tumour Foundation of Canada Brain Tumour Research Studentships for Medical Students

Brain Tumour Foundation of Canada Brain Tumour Research Studentships for Medical Students

Brain Tumour Foundation of Canada Brain Tumour Research Studentships for Undergraduate Students

Brain Tumour Foundation of Canada Brain Tumour Research Studentships for Undergraduate Students

Cancer Council ACT Research Grants

Miller Mindell Gynecologic Oncology Research Fellowship

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
Colorectal Cancer

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

Pheochromocytoma: Causes, Diagnosis, Treatment, and Breakthrough 2025 Advances in Management

Cervical Cancer: Symptoms, Causes, Stages, Diagnosis and Treatment

Craniopharyngioma: Symptoms, Diagnosis, Treatment, and 2025 Breakthroughs in Targeted Therapy and Precision Care

Malignant Schwannoma: Comprehensive Guide to Causes, Symptoms, Diagnosis, Treatment, Prognosis, and 2025 Advances in Schwannoma Care

Meningioma: Types, Symptoms, Diagnosis, Treatment, Malignancy Risk, and 2025 Breakthroughs

CancerWorld
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

Oncologists
Rana McKay

Rana R. McKay

San Diego, USA
Douglas Flora

Douglas Flora

Edgewood, USA
Matti Aapro

Matti Aapro

Genolier, Switzerland
Etienne Brain

Etienne Brain

Saint-Cloud, France
Elie Dib

Elie G. Dib

Baltimore, USA
Francesco Massari

Francesco Massari

Bologna, Italy
Md Imrul Kaes

Md Imrul Kaes

Enayetpur, Bangladesh
Karima Oualla

Karima Oualla

Fès, Morocco

Oncology Drugs
Tremelimumab (Imjudo) patient version

Imjudo (Tremelimumab) Guide for 2025: What patients need to know?

Tremelimumab (Imjudo) Updates 2025: Uses in Cancer, Dosage, Side Effects, Expectations, and More

Darovasertib for Uveal Melanoma: What Patients Need to Know

Darovasertib: A Deep Dive Into a First-in-Class PKC Inhibitor Reshaping the Treatment Landscape of Metastatic Uveal Melanoma

Amivantamab for Lung Cancer: What Patients Need to Know

Amivantamab: A Deep Dive Into Its Mechanism, Clinical Data, and Expanding Role in EGFR-Driven Non–Small Cell Lung Cancer

Relacorilant: A New Treatment Approach for Women With Platinum-Resistant Ovarian Cancer

OncoDaily Magazine
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards
awards

New Paper Alert
New GI Paper Alert for colorectal cancer

New GI Paper Alert: Survival outcomes of ERBB2-amplified metastatic colorectal cancer treated with first-line chemotherapy

CHRYSALIS-2 Trial

Treatment Outcomes With Amivantamab–Lazertinib in EGFR Mutant NSCLC: CHRYSALIS-2 Trial

GCD vx GCS

New GI Paper Alert: Durvalumab plus gemcitabine-cisplatin versus S-1 plus gemcitabine-cisplatin in advanced biliary tract cancer.

INTERACT-ION Trial

INTERACT-ION Trial: Ezabenlimab Plus mDCF Induction Improves Complete Response Rates in Anal Cancer

CCL7 Macrophages

CCL7-Positive Tumor-Associated Macrophages Drive Immune Checkpoint Resistance in Colorectal Cancer

TRYBECA-1 Trial

TRYBECA-1 Trial: Eryaspase Added to Second-Line Chemotherapy in Advanced PDAC

OncoDaily Medical Journal

Precision Oncology

10.69690/ODMJ-019-0829-4588

Harnessing Real-World Evidence to Support Precision Oncology
Opinion

Pediatric Oncology

10.69690/ODMJ-001-0829-4568

Identifying the Factors Contributing to Treatment Abandonment in Childhood Cancers at a Tertiary Care Hospital in Pakistan
Original Research

Global Oncology

10.69690/ODMJ-001-0811-4701

The Role of National and Regional Cancer Registries in Shaping Cancer Care Policies
Original Research

Pediatric Oncology

10.69690/ODMJ-001-0809-4599

Survival Outcomes of Wilms' Tumor in Pediatric Patients Treated at KFMC: A Retrospective Study of 15 years from 2007-2022
Original Research

GI Oncology

10.69690/ODMJ-018-0425-4320

Colorectal Cancer in Latin America: Quick Comment
Commentaries

GI Oncology

10.69690/ODMJ-002-0701-4309

Current Perspective of Gastro-intestinal Cancer in Guatemala
Review/Meta-Analysis

Pediatric Oncology

10.69690/ODMJ-003-0520-4233

In the Crossfire: A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group
Editorial

Pediatric Oncology

10.69690/ODMJ-018-0425-4062

CD19+ CAR-T Therapy for Relapsed or Refractory B-ALL and Burkitt Lymphoma in Children and Young Adults in the Republic of Belarus
Abstracts